In the previous issue of Critical Care, Cohen and colleagues [1] conducted a feasibility study and examined 10 burn patients and 3 healthy volunteers to determine whether there were correlations between tissue cortisol levels and plasma-free cortisol levels. Th e authors hypothesized that tissue cortisol levels are more relevant as this is what binds to cellular cortisol receptors and leads to cortisol-associated physiological changes seen. Th e authors concluded that obtaining tissue cortisol levels was feasible, but there was no correlation between tissue and plasma cortisol levels.
Diff erent methods of measuring cortisol levels are used. Th e most commonly used method measures total serum cortisol, which is free and protein (transcortin and albumin)-bound cortisol. Measuring total cortisol has poor sensitivity and specifi city and high variability in critically ill patients [2] . In addition, the immunoassays used to determine total cortisol are subject to interference, with heterophile antibodies present in some critically ill patients [3] . Using mass spectroscopy to measure cortisol is more specifi c though not widely available. Some have suggested using ratios like the free cortisol index [4] to calculate the free cortisol amount; however, these methods do not account for all proteins such as albumin, they require measurement of transcortin (a lab test not widely available), and they do not adequately account for any dilutional eff ects of massive resuscitation or of other hormonal changes (for example, vasopressin) that may aff ect plasma cortisol levels [5] . Cosyntropin stimulation testing has been advocated by some [6] [7] [8] to determine whether there is relative adrenal insuffi ciency; however, the values used as a standard for 'inadequate response' were determined in healthy adults (not critically ill patients), and there is still a high level of variability in measurements, even in the same patient [9, 10] . Th e most accurate active cortisol measure that is clinically relevant is serum-free cortisol [9, 11] . Measuring serum-free cortisol, however, is very diffi cult to perform and thus is not widely available. A widely available and less costly test that does correlate well with plasma-free cortisol levels is to measure salivary cortisol levels [12] . However, it is diffi cult to get an adequate saliva sample in critically ill patients [13] .
Th e study of Cohen and colleagues [1] is one of the fi rst to examine tissue cortisol levels. Although measuring tissue cortisol may be more pathophysiologically relevant than measuring plasma levels, it is not clear how measuring cortisol levels in tissues relates to relevant outcomes of decreased vasopressor use and improved mortality. Th ere have been many studies examining plasma cortisol levels and relating them, or treatment of relative adrenal insuffi ciency, with relevant outcomes [6, 7] . To our know ledge, there are no studies linking tissue cortisol levels to relevant outcomes. It is known that there is tissue resis tance to glucocorticoids, potentially due to local cyto kine production leading to downregulation and decreased affi nity of glucocorticoid receptors and post-receptor alterations [14] . Th us, cortisol levels may be very diff erent in diff erent tissues, raising the question of what tissue the cortisol should be measured in. With massive resusci tation, tissues can also become very edematous and this may dilute tissue
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The importance of adrenal function to survival in critically ill patients has been established; however, identifying the best method to diagnose adrenal insuffi ciency has been problematic. Multiple methods of determining adrenal function have been developed, each with its advantages and disadvantages. Serum-free cortisol levels are probably the most accurate, although obtaining this result is technically demanding. Cohen and colleagues investigated the feasibility of measuring tissue cortisol levels in burn patients and whether tissue cortisol levels could be used as a surrogate for plasma-free cortisol levels. cortisol levels, again raising the ques tions of when to obtain tissue cortisol levels, where to obtain the levels, and the accuracy of the result. Cortisol has eff ects on gluconeogenesis, vascular tone, endothelial integrity, and angiotensinogen synthesis and has anti-infl ammatory eff ects on the immune system [15] . All of these eff ects of cortisol aff ect the entire organism, suggesting that measuring circulating cortisol, rather than tissue cortisol, may be more relevant and useful from a clinical point of view. Eff orts should continue to determine more effi cient and eff ective ways to measure serum-free cortisol levels or related markers so that these assays can be widely used in a way that can benefi t critically ill patients in the intensive care unit.
